Cargando…
Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing
Spinal Muscular Atrophy is due to the loss of SMN1 gene function. The duplicate gene SMN2 produces some, but not enough, SMN protein because most transcripts lack exon 7. Thus, promoting the inclusion of this exon is a therapeutic option. We show that a somatic gene therapy using the gene for a modi...
Autores principales: | Odermatt, Philipp, Trüb, Judith, Furrer, Lavinia, Fricker, Roger, Marti, Andreas, Schümperli, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112044/ https://www.ncbi.nlm.nih.gov/pubmed/27456062 http://dx.doi.org/10.1038/mt.2016.152 |
Ejemplares similares
-
Splicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: Evidence for involvement of splicing regulatory proteins
por: Huo, Qing, et al.
Publicado: (2015) -
U5 snRNA Interactions With Exons Ensure Splicing Precision
por: Artemyeva-Isman, Olga V., et al.
Publicado: (2021) -
Pathological impact of SMN2 mis-splicing in adult SMA mice
por: Sahashi, Kentaro, et al.
Publicado: (2013) -
Recognition of atypical 5' splice sites by shifted base-pairing to U1 snRNA
por: Roca, Xavier, et al.
Publicado: (2009) -
Prp8 positioning of U5 snRNA is linked to 5′ splice site recognition
por: MacRae, Andrew J., et al.
Publicado: (2018)